US 10392376
Heterocyclic inhibitors of ATR kinase
granted A61KA61K2300/00A61K45/06
Quick answer
US patent 10392376 (Heterocyclic inhibitors of ATR kinase) held by The Board of Regents of the University of Texas System expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K2300/00, A61K45/06, A61P, A61P35/00